Literature DB >> 3578159

Effects of exogenous growth hormone on growth plate cartilage in rats.

E B Rappaport, P Snoy, W H Habig, R W Bright.   

Abstract

Slipped capital femoral epiphysis (SCFE) occurs with greater frequency in children with growth hormone deficiency than in children in the general population. This epidemiologic observation suggests that SCFE may be a complication of growth hormone deficiency, associated pituitary hormone deficiencies, growth hormone therapy, or a combination of these factors. To clarify the relationship of growth hormone treatment to SCFE, homologous growth hormone was administered to rats that were without growth hormone deficiency. This treatment was found to alter the material properties of the growth plate, increasing material stiffness and decreasing specific energy-absorptive capacity. Such material changes render the growth plate more susceptible to injury or separation. The observed effects of growth hormone on the growth plates of intact animals suggest that children without growth hormone deficiency who are treated with growth hormone may be at increased risk for growth plate separation. The experimental data also indicate that growth hormone treatment of children with this deficiency may contribute to the observed increased frequency of SCFE among these patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578159     DOI: 10.1001/archpedi.1987.04460050039026

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  2 in total

1.  Human growth hormone and the development of osteochondritis dissecans lesions.

Authors:  Waqas M Hussain; Haroon M Hussain; Mohammed S Hussain; Sherwin S W Ho
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01-11       Impact factor: 4.342

2.  Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy.

Authors:  Sogol Mostoufi-Moab; Elizabeth J Isaacoff; David Spiegel; Denise Gruccio; Jill P Ginsberg; Wendy Hobbie; Justine Shults; Mary B Leonard
Journal:  Pediatr Blood Cancer       Date:  2013-07-02       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.